Results for: Top

US Vice President Kamala Harris has acknowledged the need for immigration reform, proposing stricter border security measures including fentanyl detection and more Border Patrol agents. Her plan also includes pressuring China to crack down on fentanyl precursor chemical manufacturers. Harris’s proposed actions go further than President Biden’s current asylum restrictions, aiming for a lower average daily border encounter number before asylum applications are restricted. This comes as illegal border crossings reach record levels, exceeding 10 million since Biden’s presidency began. The ongoing debate on immigration is intensifying, with Harris criticizing Donald Trump for his efforts to block a bipartisan border funding deal and Trump questioning Harris’s inaction on border issues during her time as Vice President.

Former US President Donald Trump met with Ukrainian President Volodymyr Zelenskyy, discussing the ongoing war in Ukraine and expressing his desire to broker a peace deal if re-elected. Trump also brought up his 2019 impeachment, blaming it for hindering his ability to address the conflict. The meeting came amidst Trump’s ongoing legal battles and his repeated accusations against Google for allegedly manipulating search results to his detriment.

Israel has reportedly killed two key Hezbollah commanders, Muhammad Ali Ismail and Hussein Ahmad Ismail, in a precise airstrike in southern Lebanon. This incident marks a significant escalation in tensions between Israel and Hezbollah.

Former US President Donald Trump has accused Google of displaying only negative stories about him in search results, claiming it favors his Democratic rival, Kamala Harris. Trump threatened legal action against the tech giant if he wins the 2024 presidential election. Google refuted these allegations, stating that search results are based on factors like timeliness and popularity, and both candidates’ websites consistently rank highly for relevant queries.

Israel has claimed to have targeted Hezbollah leader Hassan Nasrallah in a ‘precise strike’, escalating tensions in the ongoing conflict with the Lebanese armed group. The Israeli military also reported the elimination of a Hezbollah missile unit commander and his deputy, alongside other operatives. The US is monitoring the situation closely, with President Biden receiving updates on the developments. The strike has sparked outrage from Iran, who called it a ‘reprehensible crime’ and a ‘reckless behaviour’.

The India Meteorological Department (IMD) has issued warnings for heavy rainfall in 10 states across India, including Uttar Pradesh, Uttarakhand, Madhya Pradesh, Tamil Nadu, Gujarat, West Bengal, Sikkim, Bihar, Kerala and Maharashtra. The IMD has issued an orange alert for Uttar Pradesh and yellow alerts for the other states, with the heaviest rainfall expected on September 28.

Today, September 28, India witnesses a flurry of significant events, from political rallies to cultural commemorations. Prime Minister Narendra Modi will address the Vijay Sankalp Maharally in Jammu, while Punjab Chief Minister Bhagwant Mann will unveil a towering statue of Bhagat Singh at Chandigarh Airport. Other notable events include President Droupadi Murmu’s visit to Telangana and a historic high-altitude marathon organized by the Indian Army in the Spiti Valley.

Jr NTR’s much-anticipated film ‘Devara-Part 1’ has made a massive splash at the box office, grossing ₹140 crore worldwide on its opening day. The action-packed film starring Jr NTR and Janhvi Kapoor has captivated audiences, solidifying its position as a major cinematic event.

Analyst Craig Irwin of Roth MKM initiated coverage on VersaBank (VBNK), setting a price target of $18. Irwin highlights the company’s potential for growth following its acquisition of Stearns Bank Holdings, which expanded VersaBank’s operations into the U.S. market.

MIRA Pharmaceuticals Inc. saw its stock surge after revealing promising preclinical data for its lead development product, Ketamir-2. This novel oral Ketamine analog achieved a 100% reversal of neuropathic pain in preclinical models, potentially offering a significant advancement in pain management. The company is aiming for human trials by 2025.